Variables | Number (n) | Percent (%) |
Antibiotic associations (n = 274) |
|
|
Monotherapy | 68 | 24.8 |
Dual therapy | 154 | 56.2 |
Triple therapy | 48 | 17.5 |
Quadruple therapy | 4 | 1.5 |
Antibiotic groups (n = 528) |
|
|
Betalactams | 254 | 48.1 |
Imidazoles | 120 | 22.7 |
Aminoglycosides | 102 | 19.3 |
Macrolides | 25 | 4.7 |
Quinolones | 18 | 3.4 |
Others* | 9 | 1.7 |
Antivirals (n = 173) |
|
|
Antiretrovirals | 158 | 91.3 |
Aciclovir | 15 | 8.7 |
Antiparasitics (n = 215) |
|
|
Trimethoprim/sulfamethoxazole | 101 | 47.0 |
Albendazole | 47 | 21.9 |
Artemether | 32 | 14.9 |
Artesunate | 24 | 11.2 |
Clindamycin | 8 | 3.7 |
Quinine | 3 | 1.4 |
Antifungals (n = 173) |
|
|
Fluconazole | 145 | 83.8 |
Miconazole | 24 | 13.9 |
Nystatin | 4 | 2.3 |